Table of Contents

1 Study Coverage

• 1.1 Drug-Eluting Stent Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Drug-Eluting Stent Market Size Growth Rate by Product
  • 1.4.2 ZES-BP
  • 1.4.3 EES
  • 1.4.4 ZES
  • 1.4.5 SES
  • 1.4.6 PES
• 1.5 Market by End User
  • 1.5.1 Global Drug-Eluting Stent Market Size Growth Rate by End User
  • 1.5.2 Cath labs
  • 1.5.3 Hospitals
  • 1.5.4 Ambulatory surgical centers (ASCs)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Drug-Eluting Stent Market Size
  • 2.1.1 Global Drug-Eluting Stent Revenue 2014-2025
  • 2.1.2 Global Drug-Eluting Stent Sales 2014-2025
• 2.2 Drug-Eluting Stent Growth Rate by Regions
  • 2.2.1 Global Drug-Eluting Stent Sales by Regions
  • 2.2.2 Global Drug-Eluting Stent Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Drug-Eluting Stent Sales by Manufacturers
  • 3.1.1 Drug-Eluting Stent Sales by Manufacturers
  • 3.1.2 Drug-Eluting Stent Sales Market Share by Manufacturers
  • 3.1.3 Global Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
• 3.2 Drug-Eluting Stent Revenue by Manufacturers
  • 3.2.1 Drug-Eluting Stent Revenue by Manufacturers (2014-2019)
  • 3.2.2 Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
• 3.3 Drug-Eluting Stent Price by Manufacturers
• 3.4 Drug-Eluting Stent Manufacturing Base Distribution, Product Types
  • 3.4.1 Drug-Eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Drug-Eluting Stent Product Type
  • 3.4.3 Date of International Manufacturers Enter into Drug-Eluting Stent Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Drug-Eluting Stent Sales by Product
• 4.2 Global Drug-Eluting Stent Revenue by Product
• 4.3 Drug-Eluting Stent Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Drug-Eluting Stent Breakdown Data by End User

6 North America

• 6.1 North America Drug-Eluting Stent by Countries
  • 6.1.1 North America Drug-Eluting Stent Sales by Countries
  • 6.1.2 North America Drug-Eluting Stent Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Drug-Eluting Stent by Product
• 6.3 North America Drug-Eluting Stent by End User

7 Europe

• 7.1 Europe Drug-Eluting Stent by Countries
  • 7.1.1 Europe Drug-Eluting Stent Sales by Countries
  • 7.1.2 Europe Drug-Eluting Stent Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Drug-Eluting Stent by Product
• 7.3 Europe Drug-Eluting Stent by End User

8 Asia Pacific

• 8.1 Asia Pacific Drug-Eluting Stent by Countries
  • 8.1.1 Asia Pacific Drug-Eluting Stent Sales by Countries
  • 8.1.2 Asia Pacific Drug-Eluting Stent Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Drug-Eluting Stent by Product
• 8.3 Asia Pacific Drug-Eluting Stent by End User

9 Central & South America

• 9.1 Central & South America Drug-Eluting Stent by Countries
  • 9.1.1 Central & South America Drug-Eluting Stent Sales by Countries
  • 9.1.2 Central & South America Drug-Eluting Stent Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Drug-Eluting Stent by Product
• 9.3 Central & South America Drug-Eluting Stent by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Drug-Eluting Stent by Countries
  • 10.1.1 Middle East and Africa Drug-Eluting Stent Sales by Countries
  • 10.1.2 Middle East and Africa Drug-Eluting Stent Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Drug-Eluting Stent by Product
• 10.3 Middle East and Africa Drug-Eluting Stent by End User

11 Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Abbott Laboratories Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Abbott Laboratories Drug-Eluting Stent Products Offered
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Biosensors International Group
  • 11.2.1 Biosensors International Group Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Biosensors International Group Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Biosensors International Group Drug-Eluting Stent Products Offered
  • 11.2.5 Biosensors International Group Recent Development
• 11.3 Boston Scientific
  • 11.3.1 Boston Scientific Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Boston Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Boston Scientific Drug-Eluting Stent Products Offered
  • 11.3.5 Boston Scientific Recent Development
• 11.4 Medtronic
  • 11.4.1 Medtronic Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Medtronic Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Medtronic Drug-Eluting Stent Products Offered
  • 11.4.5 Medtronic Recent Development
• 11.5 Terumo Corporation
  • 11.5.1 Terumo Corporation Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Terumo Corporation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Terumo Corporation Drug-Eluting Stent Products Offered
  • 11.5.5 Terumo Corporation Recent Development
• 11.6 Biotronik
  • 11.6.1 Biotronik Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Biotronik Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Biotronik Drug-Eluting Stent Products Offered
  • 11.6.5 Biotronik Recent Development
• 11.7 Cook Medical
  • 11.7.1 Cook Medical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cook Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cook Medical Drug-Eluting Stent Products Offered
  • 11.7.5 Cook Medical Recent Development
• 11.8 Envision Scientific
  • 11.8.1 Envision Scientific Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Envision Scientific Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Envision Scientific Drug-Eluting Stent Products Offered
  • 11.8.5 Envision Scientific Recent Development
• 11.9 Lepu Medical
  • 11.9.1 Lepu Medical Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Lepu Medical Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Lepu Medical Drug-Eluting Stent Products Offered
  • 11.9.5 Lepu Medical Recent Development
• 11.10 Meril Life Sciences
  • 11.10.1 Meril Life Sciences Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Meril Life Sciences Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Meril Life Sciences Drug-Eluting Stent Products Offered
  • 11.10.5 Meril Life Sciences Recent Development
• 11.11 MicroPort Medical
• 11.12 Opto Circuits
• 11.13 Shandong JW Medical Systems
• 11.14 STENTYS

12 Future Forecast

• 12.1 Drug-Eluting Stent Market Forecast by Regions
  • 12.1.1 Global Drug-Eluting Stent Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Drug-Eluting Stent Revenue Forecast by Regions 2019-2025
• 12.2 Drug-Eluting Stent Market Forecast by Product
  • 12.2.1 Global Drug-Eluting Stent Sales Forecast by Product 2019-2025
  • 12.2.2 Global Drug-Eluting Stent Revenue Forecast by Product 2019-2025
• 12.3 Drug-Eluting Stent Market Forecast by End User
• 12.4 North America Drug-Eluting Stent Forecast
• 12.5 Europe Drug-Eluting Stent Forecast
• 12.6 Asia Pacific Drug-Eluting Stent Forecast
• 12.7 Central & South America Drug-Eluting Stent Forecast
• 12.8 Middle East and Africa Drug-Eluting Stent Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Drug-Eluting Stent Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body’s natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.
The growing prevalence of these diseases is due to factors such as smoking, obesity, alcohol consumption, and unhealthy lifestyle. Furthermore, the rapidly increasing older population is driving the market because aging increase the chances of developing cardiovascular diseases including atherosclerosis.
The global market for the drug-eluting stent is highly fragmented due to the presence of several well-established vendors. The competition is expected to intensify with an increase in product portfolio extensions with next-generation products, technological innovations, and mergers and acquisitions.
The global Drug-Eluting Stent market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drug-Eluting Stent market based on company, product type, end user and key regions.

This report studies the global market size of Drug-Eluting Stent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug-Eluting Stent in these regions.
This research report categorizes the global Drug-Eluting Stent market by top players/brands, region, type and end user. This report also studies the global Drug-Eluting Stent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Biosensors International Group
Boston Scientific
Medtronic
Terumo Corporation
Biotronik
Cook Medical
Envision Scientific
Lepu Medical
Meril Life Sciences
MicroPort Medical
Opto Circuits
Shandong JW Medical Systems
STENTYS

Market size by Product
ZES-BP
EES
ZES
SES
PES
Market size by End User
Cath labs
Hospitals
Ambulatory surgical centers (ASCs)

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drug-Eluting Stent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drug-Eluting Stent market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug-Eluting Stent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug-Eluting Stent submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drug-Eluting Stent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug-Eluting Stent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.